Leerink Partnrs Has Pessimistic View of KPTI FY2025 Earnings
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Equities research analysts at Leerink Partnrs lowered their FY2025 earnings estimates for shares of Karyopharm Therapeutics in a report issued on Wednesday, February 19th. Leerink Partnrs analyst J. Chang now anticipates that the company will earn ($0.75) per share for the year, down from their previous estimate […]
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Equities research analysts at Leerink Partnrs lowered their FY2025 earnings estimates for shares of Karyopharm Therapeutics in a report issued on Wednesday, February 19th. Leerink Partnrs analyst J. Chang now anticipates that the company will earn ($0.75) per share for the year, down from their previous estimate […]
